| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.40B | 27.06B | 27.61B | 29.93B | 23.33B | 20.49B |
| Gross Profit | 17.34B | 17.05B | 16.46B | 16.12B | 13.95B | 13.29B |
| EBITDA | 7.59B | 7.50B | 6.90B | 6.42B | 6.11B | 5.77B |
| Net Income | 3.43B | 3.31B | 3.08B | 2.76B | 2.57B | 2.44B |
Balance Sheet | ||||||
| Total Assets | 49.34B | 51.87B | 48.33B | 49.52B | 46.78B | 41.98B |
| Cash, Cash Equivalents and Short-Term Investments | 1.64B | 1.92B | 1.62B | 1.91B | 2.25B | 1.79B |
| Total Debt | 12.70B | 12.45B | 12.11B | 13.45B | 13.96B | 13.49B |
| Total Liabilities | 24.11B | 24.25B | 23.29B | 24.95B | 24.78B | 22.97B |
| Stockholders Equity | 24.51B | 26.86B | 24.32B | 23.74B | 21.46B | 18.54B |
Cash Flow | ||||||
| Free Cash Flow | 2.63B | 2.80B | 2.87B | 2.31B | 2.45B | 2.33B |
| Operating Cash Flow | 6.33B | 6.32B | 6.26B | 5.59B | 5.37B | 4.96B |
| Investing Cash Flow | -3.83B | -3.58B | -3.08B | -3.24B | -3.35B | -1.95B |
| Financing Cash Flow | -2.57B | -2.81B | -3.48B | -2.78B | -1.82B | -2.43B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $5.75B | 15.42 | 10.25% | 1.84% | 4.83% | 52.47% | |
67 Neutral | $19.52B | 12.44 | 8.49% | 5.02% | -3.62% | -17.91% | |
66 Neutral | €97.51B | 28.42 | 13.92% | 2.01% | 1.46% | 12.62% | |
65 Neutral | €40.34B | 14.40 | 11.84% | 2.70% | 1.09% | -0.94% | |
64 Neutral | €3.74B | 17.26 | 2.27% | 7.00% | -2.71% | -57.75% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |